Nanox Imaging is trading 10.86% up at $0.92, extending its rebound ahead of the company’s September 9, 2026 second-quarter results.

  • The company scheduled the release before market open, followed by an 8:30 a.m. ET conference call.
  • Investors are likely focused on revenue, cash availability, and going-concern risks.
  • The broader healthcare sector is declining, making the company-specific earnings catalyst the stronger explanation.